Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

9.41 

0.04 0.5%

as of Jun 02 '23

52 Week Range:

1.81 11.90


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. It operates 2,105 pathology sites; 11 day hospital sites; and 134 imaging sites. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22
Equity (BVPS) 3.91
3.56
3.56
3.17
3.08
3.01
2.19
2.03
2.04
2.11
growth rate -9.0% 0.0% -11.0% -2.8% -2.3% -27.2% -7.3% 0.5% 3.4%
Earnings BIT 292.00
255.48
229.30
166.90
117.30
80.50
107.60
86.10
270.80
488.40
growth rate -12.5% -10.3% -27.2% -29.7% -31.4% 33.7% -20.0% 214.5% 80.4%
Avg.PE 59.00
52.60
-2.84
-2.84
-2.84
-2.84
6.53
growth rate -10.9% -100.0% 0.0% 0.0% 0.0% 100.0%
ROA 3.03
3.82
4.01
3.39
1.98
-15.34
0.13
1.73
-1.78
1.05
growth rate 26.1% 5.0% -15.5% -41.6% -100.0% 100.0% 1,230.8% -100.0% 100.0%
ROE 4.60
5.72
5.99
5.26
3.07
-24.07
0.22
2.89
-3.54
2.31
growth rate 24.4% 4.7% -12.2% -41.6% -100.0% 100.0% 1,213.6% -100.0% 100.0%
ROIC 5.08
5.49
5.41
4.87
3.26
-16.03
1.06
2.85
-2.16
2.33
growth rate 8.1% -1.5% -10.0% -33.1% -100.0% 100.0% 168.9% -100.0% 100.0%
Cur. Ratio 1.02
0.98
0.80
0.73
0.89
0.80
0.67
0.88
1.36
0.48
growth rate -3.9% -18.4% -8.8% 21.9% -10.1% -16.3% 31.3% 54.6% -64.7%
Quick Ratio 0.89
0.86
0.70
0.44
0.70
0.65
0.58
0.69
0.35
0.37
growth rate -3.4% -18.6% -37.1% 59.1% -7.1% -10.8% 19.0% -49.3% 5.7%
Leverage 1.50
1.49
1.50
1.61
1.49
1.67
1.72
1.63
2.36
2.04
growth rate -0.7% 0.7% 7.3% -7.5% 12.1% 3.0% -5.2% 44.8% -13.6%
Balance Sheet Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22
Acct.Receivable 152.00
136.09
175.20
120.60
130.10
165.90
186.30
248.80
184.10
219.70
growth rate -10.5% 28.7% -31.2% 7.9% 27.5% 12.3% 33.6% -26.0% 19.3%
Acct.Payable 98.00
103.30
139.00
156.50
203.30
209.20
222.90
203.00
195.50
169.60
growth rate 5.4% 34.6% 12.6% 29.9% 2.9% 6.6% -8.9% -3.7% -13.3%
Cur.Assets 212.00
204.58
310.20
250.30
266.50
287.00
346.50
1,341.60
330.90
371.80
growth rate -3.5% 51.6% -19.3% 6.5% 7.7% 20.7% 287.2% -75.3% 12.4%
Total Assets 3,985.00
3,742.28
3,918.10
3,624.60
3,114.10
3,126.30
3,352.70
4,588.30
3,782.20
4,136.80
growth rate -6.1% 4.7% -7.5% -14.1% 0.4% 7.2% 36.9% -17.6% 9.4%
Cash 35.00
27.46
50.00
82.30
95.50
84.00
119.70
137.50
70.10
81.30
growth rate -21.5% 82.1% 64.6% 16.0% -12.0% 42.5% 14.9% -49.0% 16.0%
Inventory 26.00
27.26
28.20
25.50
25.10
22.20
22.70
26.90
35.90
49.20
growth rate 4.9% 3.4% -9.6% -1.6% -11.6% 2.3% 18.5% 33.5% 37.1%
Cur.Liabilities 220.00
254.22
428.70
280.80
331.60
374.90
392.60
995.30
684.70
641.30
growth rate 15.6% 68.6% -34.5% 18.1% 13.1% 4.7% 153.5% -31.2% -6.3%
Liabilities 1,306.00
1,371.17
1,502.70
1,196.90
1,245.00
1,307.40
1,301.60
2,657.00
1,924.90
2,215.20
growth rate 5.0% 9.6% -20.4% 4.0% 5.0% -0.4% 104.1% -27.6% 15.1%
LT Debt 1,077.00
1,099.92
1,057.30
897.10
879.40
861.70
812.30
824.30
258.10
606.10
growth rate 2.1% -3.9% -15.2% -2.0% -2.0% -5.7% 1.5% -68.7% 134.8%
Equity 2,369.33
2,413.60
2,426.10
1,867.60
1,818.90
2,051.10
1,931.30
1,857.30
1,921.60
growth rate 1.9% 0.5% -23.0% -2.6% 12.8% -5.8% -3.8% 3.5%
Common Shares 518.00
521.00
523.00
530.00
539.00
540.00
2,424.20
2,671.10
2,672.30
2,575.60
2,422.90
growth rate 0.6% 0.4% 1.3% 1.7% 0.2% 348.9% 10.2% 0.0% -3.6% -5.9%
Cash Flow Statement Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22
Capital Expenditures 71.00
85.14
134.90
94.00
74.50
57.00
79.60
49.30
48.40
81.40
growth rate 19.9% 58.5% -30.3% -20.7% -23.5% 39.7% -38.1% -1.8% 68.2%
Cash Dividends 92.57
53.70
64.40
58.40
56.90
52.30
21.20
56.30
98.10
growth rate -42.0% 19.9% -9.3% -2.6% -8.1% -59.5% 165.6% 74.3%
Cash From OA 264.00
260.74
239.40
285.10
212.20
202.20
127.60
406.90
525.90
586.80
growth rate -1.2% -8.2% 19.1% -25.6% -4.7% -36.9% 218.9% 29.3% 11.6%
FCF per Share 0.09
0.21
0.17
0.12
0.04
0.11
0.13
0.08
0.10
0.41
growth rate 133.3% -19.1% -29.4% -66.7% 175.0% 18.2% -38.5% 25.0% 310.0%
FCF 123.00
158.00
137.00
-6.00
80.00
92.00
129.00
28.00
267.00
465.00
505.40
growth rate 28.5% -13.3% -100.0% 100.0% 15.0% 40.2% -78.3% 853.6% 74.2% 8.7%
Income Statement Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22
Sales 1,440.00
1,524.12
1,579.70
1,641.90
1,658.60
1,704.60
1,566.40
1,569.80
1,914.20
2,336.70
growth rate 5.8% 3.7% 3.9% 1.0% 2.8% -8.1% 0.2% 21.9% 22.1%
Op.Income 292.00
255.48
229.30
166.90
117.30
80.50
107.60
86.10
270.80
488.40
growth rate -12.5% -10.3% -27.2% -29.7% -31.4% 33.7% -20.0% 214.5% 80.4%
IBT 183.73
6.10
56.40
-512.80
29.50
82.00
62.80
167.80
416.90
growth rate -96.7% 824.6% -100.0% 100.0% 178.0% -23.4% 167.2% 148.5%
Net Income 150.00
114.55
127.50
74.90
-516.80
4.10
55.30
-70.50
43.70
307.90
growth rate -23.6% 11.3% -41.3% -100.0% 100.0% 1,248.8% -100.0% 100.0% 604.6%
EPS 0.22
0.29
0.31
0.26
0.14
-0.96
0.01
0.09
-0.11
0.07
growth rate 31.8% 6.9% -16.1% -46.2% -100.0% 100.0% 800.0% -100.0% 100.0%
Gross Profit 670.00
687.07
711.30
702.50
663.30
566.30
525.10
511.70
732.90
1,004.50
growth rate 2.6% 3.5% -1.2% -5.6% -14.6% -7.3% -2.6% 43.2% 37.1%

Quarterly Statements

Item Name Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Earnings BIT 56.75
186.75
186.75
growth rate 229.1% 0.0%
Balance Sheet Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Acct.Receivable 184.10
304.50
304.50
219.70
219.70
growth rate 65.4% 0.0% -27.9% 0.0%
Acct.Payable 205.90
209.20
209.20
169.60
169.60
growth rate 1.6% 0.0% -18.9% 0.0%
Cur.Assets 330.90
479.80
479.80
371.80
371.80
growth rate 45.0% 0.0% -22.5% 0.0%
Total Assets 3,782.20
3,920.20
3,920.20
4,136.80
4,136.80
growth rate 3.7% 0.0% 5.5% 0.0%
Cash 70.10
107.50
107.50
81.30
81.30
growth rate 53.4% 0.0% -24.4% 0.0%
Inventory 35.90
45.10
45.10
49.20
49.20
growth rate 25.6% 0.0% 9.1% 0.0%
Cur.Liabilities 684.70
689.80
689.80
641.30
641.30
growth rate 0.7% 0.0% -7.0% 0.0%
Liabilities 1,924.90
1,982.90
1,982.90
2,215.20
2,215.20
growth rate 3.0% 0.0% 11.7% 0.0%
LT Debt 264.50
329.80
329.80
606.10
606.10
growth rate 24.7% 0.0% 83.8% 0.0%
Equity 1,857.30
1,937.30
1,937.30
1,921.60
1,921.60
growth rate 4.3% 0.0% -0.8% 0.0%
Common Shares 2,575.60
2,461.30
2,461.30
2,422.90
2,422.90
growth rate -4.4% 0.0% -1.6% 0.0%
Cash Flow Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Capital Expenditures 13.35
18.60
18.60
growth rate 39.3% 0.0%
Cash Dividends 20.05
20.00
20.00
growth rate -0.3% 0.0%
Cash From OA 137.35
174.80
174.80
growth rate 27.3% 0.0%
FCF 124.00
156.20
156.20
growth rate 26.0% 0.0%
Income Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Sales 481.00
669.00
669.00
growth rate 39.1% 0.0%
Op.Income 56.75
186.75
186.75
growth rate 229.1% 0.0%
IBT 31.05
168.20
168.20
growth rate 441.7% 0.0%
Net Income -9.55
116.60
116.60
growth rate 100.0% 0.0%
Gross Profit 187.25
314.80
314.80
growth rate 68.1% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (39.03)

YOY Growth Grade:

E (20.45)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

Current EPS is negative, therefore value price cannot be calculated.

PE and EPS

Historical Current Forward
PE 6.53 -123.82
EPS / Growth -0.08

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 1.0% 1.0%
Future PE 0.01 1.01 1.01
Future EPS 0.00 0.00 0.00
Value Price
MOS %
0.00
-100.0%
0.00
-100.0%
0.00
-100.0%
MOS Price 0.00 0.00 0.00
IRT 99.00 99.00 99.00

Graham Number:

Current EPS is negative, therefore Graham Number cannot be calculated.
NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.